Clinical Trial Update: Ketamine Infusion in Neurologic Deficit [Phase 2, Phase 3]

View source ↗

Summary

The document reports a Phase 2/3 clinical trial evaluating ketamine infusion for neurologic deficits after subarachnoid hemorrhage, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Unity Health Toronto | Conditions: Subarachnoid Hemorrhage | Phase 2, Phase 3 | Status: COMPLETED